The level and duration of RSV-specific maternal IgG in infants in kilifi Kenya

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Ochola, Rachel ^a   Sande, Charles ^a   Fegan, Gregory ^a,b   Scott, Paul D ^c   Medley, Graham F ^c   Cane, Patricia A ^d   Nokes, D James ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

AGE DISTRIBUTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KENYA; MAJOR CLINICAL STUDY; MALE; NEWBORN; PLASMA HALF LIFE; PREVALENCE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; SEROLOGY; UMBILICAL CORD BLOOD; AGING; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; BLOOD; BLOOD SAMPLING; EPIDEMIOLOGY; FETOMATERNAL TRANSFUSION; FETUS BLOOD; IMMUNOLOGY; INFANT; PREGNANCY; TITRIMETRY;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

AGING; ANTIBODY SPECIFICITY; BLOOD SPECIMEN COLLECTION; COHORT STUDIES; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; KENYA; MATERNAL-FETAL EXCHANGE; MODELS, IMMUNOLOGICAL; PREGNANCY; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TITRIMETRY;

EID: 77949532244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008088     Document Type: Article

References (29)

1. Loscertales MP, Roca A, Ventura PJ, Abacassamo F, Dos Santos F, et al. (2002) Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique. Pediatr Infect Dis J 21: 148-55.
2. Roca A, Abacassamo F, Loscertales M-P, Quinto L, Gomez-Olive L X, et al. (2002) Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique. J Med Virol 67: 616-23.
3. Zambon MC, Stockton JD, Clewley JP, Fleming DM (2001) Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358: 1410-6.
4. Roca A, Quinto L, Abacassamo F, Loscertales MP, Gomez-Olive FX, et al. (2003) Antibody response after RSV infection in children younger than 1 year of age living in a rural area of Mozambique. J Med Virol 69: 579-87.
5. Boeck KD (1996) Respiratory syncytial virus bronchiolitis: clinical aspects and epidemiology. Monaldi Arch Chest Dis 51: 210-3.
6. Brandenburg AH, Groen J, van Steensel-Moll HA, Claas EC, Rothbarth PH, et al. (1997) Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 52: 97-104.
7. Cox MJ, Azevedo RS, Cane PA, Massad E, Medley GF (1998) Seroepidemi- ological study of respiratory syncytial virus in Sao Paulo state, Brazil. J Med Virol 55: 234-9.
8. Lamprecht CL, Krause HE, Mufson MA (1976) Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 134: 211-7.
9. Hall C, Kopelman A, Douglas RJ, Geiman J, Meagher M (1979) Neonatal respiratory syncytial virus infection. New England Journal of Medicine 300: 393-396.
10. Neligan GA, Steiner H, Gardner PS, McQuillin J (1970) Respiratory syncytial virus infection of the newborn. Br Med J 3: 146-7.
11. Nandapalan N, Taylor CE, Greenwell J, Scott M, Scott R, et al. (1986) Seasonal variations in maternal serum and mammary immunity to RS virus. J Med Virol 20: 79-87.
12. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL (1981) Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98: 708-15.
13. Glezen WP, Taber LH, Frank AL, Kasel JA (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140: 543-6.
14. Ogilvie MM, Vathenen AS, Radford M, Codd J, Key S (1981) Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol 7: 263-71.
15. Ward KA, Lambden PR, Ogilvie M M, Watt PJ (1983) Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J Gen Virol 64 (Pt 9): 1867-76.
16. PREVENT (1997) Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group. Pediatrics 99: 93-9.
17. IMPACT (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 102: 531-7.
18. Munoz FM, Piedra PA, Glezen WP (2003) Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 21: 3465-7.
19. Englund J, Glezen WP, Piedra PA (1998) Maternal immunization against viral disease. Vaccine 16: 1456-63.
20. Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, et al. (2008) Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis 46: 50-57.
21. Nokes DJ, Okiro EA, Ngama M, White LJ, Ochola R, et al. (2004) Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life. J Infect Dis 190: 1828-32.
22. Ministry of Finance and Planning. Analytical report on population projections. Vol VII. Central Bureau of Statistics 2002. Nairobi, Kenya: Central Bureau of Statistics, Government of Kenya.
23. Wilson SD, Roberts K, Hammond K, Ayres JG, Cane PA (2000) Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies. J Med Virol 61: 81-4.
24. Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA (1979) Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child 133: 1240-3.
25. Hacimustafaoglu M, Celebi S, Aynaci E, Sinirtas M, Koksal N, et al. (2004) The progression of maternal RSV antibodies in the offspring. Arch Dis Child 89: 52-3.
26. Ebihara T, Endo R, Kikuta H, Ishiguro N, Ishiko H, Kobayashi K (2004) Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus. J Med Virol 72: 304-6.
27. Caceres VM, Strebel PM, Sutter RW (2000) Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 31: 110-9.
28. Lee MS, Mendelman PM, Sangli C, Cho I, Mathie SL, et al. (2001) Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. J Infect Dis 183: 1281-4.
29. Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, et al. (2009) Seasonal variation of maternally derived Respiratory Syncytial Virus antibodies and association with infant hospitalizations for Respiratory Syncytial Virus. J Pediatr 154: 296-8.